- Home
- NKTR vs INFU Comparison
NKTR vs INFU Comparison
Compare NKTR & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- INFU
- Stock Information
- Founded
- NKTR 1990
- INFU 2005
- Country
- NKTR United States
- INFU United States
- Employees
- NKTR N/A
- INFU N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- INFU Medical/Dental Instruments
- Sector
- NKTR Health Care
- INFU Health Care
- Exchange
- NKTR Nasdaq
- INFU Nasdaq
- Market Cap
- NKTR 108.3M
- INFU 104.4M
- IPO Year
- NKTR 1994
- INFU N/A
- Fundamental
- Price
- NKTR $25.69
- INFU $6.17
- Analyst Decision
- NKTR Strong Buy
- INFU
- Analyst Count
- NKTR 6
- INFU 0
- Target Price
- NKTR $77.50
- INFU N/A
- AVG Volume (30 Days)
- NKTR 4.5M
- INFU 288.5K
- Earning Date
- NKTR 08-07-2025
- INFU 08-07-2025
- Dividend Yield
- NKTR N/A
- INFU N/A
- EPS Growth
- NKTR N/A
- INFU 3654.89
- EPS
- NKTR N/A
- INFU 0.15
- Revenue
- NKTR $87,248,000.00
- INFU $137,582,000.00
- Revenue This Year
- NKTR N/A
- INFU $11.08
- Revenue Next Year
- NKTR N/A
- INFU $8.02
- P/E Ratio
- NKTR N/A
- INFU $41.38
- Revenue Growth
- NKTR N/A
- INFU 7.98
- 52 Week Low
- NKTR $6.48
- INFU $4.61
- 52 Week High
- NKTR $37.38
- INFU $9.97
- Technical
- Relative Strength Index (RSI)
- NKTR 70.35
- INFU 53.42
- Support Level
- NKTR $8.27
- INFU $5.84
- Resistance Level
- NKTR $37.38
- INFU $6.53
- Average True Range (ATR)
- NKTR 3.58
- INFU 0.27
- MACD
- NKTR 1.48
- INFU -0.03
- Stochastic Oscillator
- NKTR 59.68
- INFU 47.86
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.